NCT07122063 Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SYS6045 in Patients With HER2-Positive, Expressing, or Mutated Advanced Malignant Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT07106814 Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors Status RECRUITING Phase EARLY_PHASE1
NCT07101549 Treating Nectin-4-positive Advanced Solid Tumors With R-Star001 (Nectin-4-CART-IL18) Status NOT_YET_RECRUITING Phase PHASE1
NCT07093970 A Study of MRG006A in the Treatment of Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT07077434 A Study to Assess Safety, Tolerability and Drug Levels of BMS-986504 in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT07061639 A Study of QLS5133 Monotherapy in Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07060989 A Study of Safety, Tolerability and Preliminary Efficacy of NTS071 in Subjects With Advanced Solid Tumors Harboring a TP53 Y220C Mutation Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07053904 Phase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors Status ENROLLING_BY_INVITATION Phase PHASE1
NCT07046650 Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors Status RECRUITING Phase PHASE2
NCT07042100 A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors. Status RECRUITING Phase PHASE1
NCT07038369 A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT07036133 Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment Status RECRUITING Phase PHASE1
NCT07019779 Study of CM518D1 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06998173 Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DAT-1604 in Advanced Solid Tumor Status NOT_YET_RECRUITING Phase PHASE1
NCT06993870 Phase I Study of HBT-708 for Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1